NIFTY 50 23344.75 ▲ (0.61%)
NIFTY NEXT 50 65106.15 ▲ (0.08%)
NIFTY 100 24048.8 ▲ (0.51%)
NIFTY MIDCAP 100 55106.2 ▲ (0.91%)
NIFTY SMALLCAP 100 17864.65 ▲ (1.09%)
NIFTY SMALLCAP 250 16841.4 ▲ (0.84%)
NIFTY MIDCAP SELECT 12356.5 ▲ (0.87%)
NIFTY TOTAL MARKET 12304.6 ▲ (0.6%)
NIFTY BANK 49350.8 ▲ (1.67%)
SENSEX 77073.44 ▲ (0.59%)
BSE BANKEX 56036.23 ▲ (2.03%)

Shareholding Pattern: Shareholding Pattern Eiko Lifesciences FY(Q2-Sep 2024-2025)

[fetch_key]
Shareholding results summarize the composition of a company’s shareholder base, revealing how ownership is distributed among various investors. This information is crucial for assessing the level of institutional and retail investment in the company. By examining shareholding results, analysts can gauge investor sentiment and the potential impact on stock performance. Eiko Lifesciences has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name Previous Quarter Quantity Current Quarter Quantity Previous Quarter Shares(in %) Current Quarter Shares(in %) Quarter to Quarter Difference
Promoters 33.82 Lakh 33.82 Lakh 24.4 24.4 0
Public 1.05 Cr 1.05 Cr 75.6 75.6 0
DII 0 0 0 0 0
FII 0 0 0 0 0
Government 0 0 0 0 0
Promoters shareholding remained stable, at 24.4% in both June 2024 and September 2024. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 75.6% in both June 2024 and September 2024. This indicates that the Public control over the company did not change during this period.

Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.

Shareholder Name Previous Quarter Quantity Current Quarter Quantity Previous Quarter Shares (in %) Current Quarter Shares (in %) Quarter-to-Quarter Difference (%)
Resident Individuals holding nominal share capital up to Rs. 2 lakhs 26.23 Lakh 28.61 Lakh 18.93 20.64 + 1.71 %
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 41.57 Lakh 39.38 Lakh 29.99 28.41 -1.58 %
JOYANTA KUMAR JANA 0 2.75 Lakh 0 1.98 +1.98%
BHAVINKUMAR VINAYCHAND SHAH 1.86 Lakh 1.88 Lakh 1.34 1.35 + 0.01 %
Non Resident Indians (NRIs) 1.88 Lakh 2.38 Lakh 1.35 1.71 + 0.36 %
Bodies Corporate 31.40 Lakh 30.70 Lakh 22.65 22.15 -0.5 %
V SQUARE PHARMACHEM . 0 3.14 Lakh 0 2.26 +2.26%
ASHIKA GLOBAL FINANCE PVT. . 0 5.92 Lakh 0 4.27 +4.27%
2B BLACK BIO LLP . 0 20.50 Lakh 0 14.79 +14.79%
Any Other (specify) 3.20 Lakh 3.21 Lakh 2.31 2.32 + 0.01 %
HUF 3.20 Lakh 3.19 Lakh 2.31 2.3 -0.01 %
Clearing Members 391 2.40 K 0 0.02 + 0.02 %
DEEPAK JUGALKISHORE CHOKHANI 1.66 Lakh 0 1.2 0 -1.2%
ARITRO ASHISH ROY 2.60 Lakh 0 1.88 0 -1.88%
V SQUARE PHARMACHEM 4.15 Lakh 0 2.99 0 -2.99%
ASHIKA GLOBAL FINANCE PVT 5.92 Lakh 0 4.27 0 -4.27%
2B BLACK BIO LLP 20.42 Lakh 0 14.73 0 -14.73%
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 1.71 %.Observations show a significant difference of -1.58 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, BHAVINKUMAR VINAYCHAND SHAH has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.36 %.Observations show a significant difference of -0.5 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.01 %.Observations show a significant difference of -0.01 % in HUF’s financial performance between quarters.Leading the way to higher stakeholding, Clearing Members has significantly boosted stakeholding by an impressive 0.02 %.JOYANTA KUMAR JANA had no shares in the previous quarter but now holds 1.98% of shares in the current quarter.V SQUARE PHARMACHEM . had no shares in the previous quarter but now holds 2.26% of shares in the current quarter.ASHIKA GLOBAL FINANCE PVT. . had no shares in the previous quarter but now holds 4.27% of shares in the current quarter.2B BLACK BIO LLP . had no shares in the previous quarter but now holds 14.79% of shares in the current quarter.DEEPAK JUGALKISHORE CHOKHANI had 1.2% of shares in the previous quarter but exited in the current quarter.ARITRO ASHISH ROY had 1.88% of shares in the previous quarter but exited in the current quarter.V SQUARE PHARMACHEM had 2.99% of shares in the previous quarter but exited in the current quarter.ASHIKA GLOBAL FINANCE PVT had 4.27% of shares in the previous quarter but exited in the current quarter.2B BLACK BIO LLP had 14.73% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Eiko Lifesciences”]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post